Asphaug L, Akslen LA, Blix ES, Boge B, Borgen EF, Brekke MB, Falk RS, Geitvik GA, Gilje B, Gravdehaug B, Heie A, Janssen E, Kiserud CE, Kursetgjerde T, Langerød A, Lømo J, Mannsåker B, Mortensen E, Olsson P, Porojnicu AC, Raj SX, Roe OD, Russnes HEG, Skjerven HK, Songe-Møller Set al.(2025) Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives Clin Breast Cancer, 25(6), e721-e730 DOI 10.1016/j.clbc.2025.04.011, PubMed 40348620
Bröckelmann PJ, Böll B, Molin D, Schneider G, Leppä S, Meissner J, Kamper P, Hutchings M, Christensen JH, Schnetzke U, Fuchs M, Jablonski J, Eichenauer DA, von Tresckow B, Klapper W, Kobe C, Borchmann P, Fosså A(2025) Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients Hemasphere, 9(8), e70190 DOI 10.1002/hem3.70190, PubMed 40832013
Bøhn SH, Reinertsen KV, Kiserud CE, Loge JH, Fosså A, Skaali T, Blomhoff R, Oldervoll LM, Courneya KS, Raastad T, Nilsen TS, Wisløff T, Lie HC, Berge T, Edvardsen E, Fagerli UM, Fjerstad E, Gjerset GM, Haavik I, Henriksen HB, Rutkovskiy A, Sandberg G, Seland M, Slott M, Tjessem KHet al.(2025) Effects of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Chronic Fatigue: Protocol for a Randomized Controlled Trial (REFUEL) JMIR Res Protoc, 14, e69336 DOI 10.2196/69336, PubMed 40882189